Publicaciones científicas en Inglés. 2010

Barana A, Amorós I, Caballero R, Gómez R, Osuna L, Lillo MP, Blázquez C, Guzmán M, Delpón E, Tamargo J.
Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.
Cardiovasc Res. 2010;85:56-67.

Amorós I, Barana A, Caballero R, Gómez R, Osuna L, Lillo MP, Tamargo J, Delpón E.
Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channnels in a receptor-independent manner.
J Mol Cell Cardiol 2010;85:56-67 .

Tamargo J, Amorós I, Barana A, Caballero R, Delpón E.
New investigational drugs for the management of acute heart failure syndromes.
Current Med Chem 2010;17:363-390.

Tamargo J, Duarte J, Caballero R, Delpón E.
Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure.
Curr Opin Investig Drugs 2010;11:1039-47.

Romero M, Jiménez R, Hurtado B, Moreno JM, Rodríguez-Gómez I, López-Sepúlveda R, Zarzuelo A, Pérez-Vizcaino F, Tamargo J, Vargas F, Duarte J.
Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats.
Eur J Pharmacol 2010;627:242-50.

Modrego J, Maroto L, Tamargo J, Azcona L, Mateos-Cáceres P, Segura A, Moreno-Herrero R, Pérez-Castellanos N, Delpón E, Pérez-Villacastín J, Rodríguez E, Macaya C, López-Farré AJ.
Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation.
J Cardiovasc Electrophysiol. 2010;21:859-68.

López Farré AJ, Tamargo J, Mateos-Cáceres PJ, Azcona L, Macaya C.
Old and New Molecular Mechanisms Associated with Platelet Resistance to Antithrombotics.
Pharm Res. 2010;27:2365-73.

Prystowsky EN, Camm J, Lip GYH, Allessie M, Bergmann JF, Breithardt G, Brugada J, Crijns H, Ellionor PT, Mark D, Naccarelli G, Packer D, Tamargo J.
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.
J Cardiovasc Electrophysiol 2010;21:946-958.

Tamargo J, Caballero R, Gómez R, Delpón E.
Cardiac electrophysiological effects of nitric oxide.
Cardiovasc Res. 2010;87:593-600.

Romero M, Jiménez R, Sánchez M, López-Sepúlveda R, Zarzuelo A, Tamargo J, Pérez-Vizcaíno F, Duarte J.
Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation.
Atherosclerosis. 2010;212:78-85.

Caballero R, González de la Fuente M ; Gómez R, Barana A, Amorós I, Osuna L, Dolz-Gaitón P, Almendral J, Atienza F, Fernández-Avilés F, Pita A, Jorge Rodríguez-Roda J, Pinto A, Tamargo J, Delpón E.
In humans chronic atrial fibrillation decreases I to1 and I Kur differentially on each atria and increases I Ks in both.
J Am Coll Cardiol 2010 ;55:2346-2354.

Caballero R, Dolz-Gaitón P, Gómez R, Amorós I, Barana A, González de la Fuente M , Osuna L, Duarte J, López-Izquierdo A, Moraleda I, Gálvez E, Sánchez-Chapula JA, Tamargo J, Delpón E.
Flecainide increases Kir2.1 currents by interacting with Cysteine-311 decreasing the polyamine-induced rectification.
Proc Natl Acad Sci U S A 2010;107:15631-15636.

Burashnikov E, Pfeiffer R, Barajas-Martinez H, Delpón E, Hu D, Desai M, Borggrefe M, Häissaguerre M, Kanter R, Pollevick Gd, Guerchicoff A, Laiño R, Marieb M, Nademanee K, Nam Gb, Robles R, Schimpf R, Stapleton Dd, Viskin S, Winters S, Wolpert C, Zimmern S, Veltmann C, Antzelevitch C.
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.
Heart Rhythm. 2010; 7:1872-1882

Barrios V, Navarro A, Esteras A, Luque M, Romero J, Tamargo J, Prieto L, Carrasco JL, Herranz I, Navarro-Cid J, Ruilope LM
Antihypertensive efficacy and tolerability oflercanidipine in daily clinical practice. The ELYPSE Study
Russian Journal of Cardiology 2010;4:72-77